00:18 – Introduction by Deborah Davis Non-Executive Chair
06:28 – Overview of Diacuetics, Peter Keeling Founder and CEO
14:38 – Introduction to DXRX, Ryan Keeling Chief Innovation Officer
47:14 – Industry expert panel discussion Led by Susanne Munksted, Chief Precision Officer.
1:15:21 – Q&A
1:34:38 – Our opportunity & strategic roadmap, Peter Keeling Founder and CEO
1:41:31 – Business model & KPIs, Philip White CFO
1:49:10 – Conclusion, Peter Keeling Founder and CEO
1:50:35 – Q&A
1:59:56 – Closing remarks, Peter Keeling Founder and CEO
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.
DXRX is the world’s first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.
PIWORLD provides investors with the latest news and insight to listed companies and their management teams through either live or recorded results presentations, corporate overviews, management interviews and Capital Market Days. Together with interviews from leading fund managers, market specialists and esteemed private investors, we aim to keep the private investor community up to date and informed.
PIWORLD delivers high quality audio and video content to present anything from full-year and interim results to Capital Markets Days and corporate overviews. We bridge the gap between listed companies and the private investor community, who drive the share price and provide liquidity, providing a time and cost effective medium to reach this diverse and important audience.
